- Record: found
- Abstract: not found
- Article: not found
LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM)
N.S. Vasudev, G. AINSWORTH, S Brown, L Pickering, T.S. Waddell, K. Fife, R. GRIFFITHS, A. Sharma, E Katona, H Howard, G Velikova, A Maraveyas, J.E. BROWN, B Venugopal, P Patel, A Jain, S. Symeonides, P.D. Nathan, F Collinson, T.B. Powles, NS Vasudev, S. BROWN, TS Waddell, L. PICKERING
2021
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.